References
- Brissová M, Petro M, Lacík I, Powers AC, Wang T. Evaluation of microcapsule permeability via inverse size exclusion chromatography. Anal Biochem 1996; 242: 104–11
- Calafiore R, Basta G, Luca G, Lemmi A, Montanucci MP, Calabrese G, Racanicchi L, Mancuso F, Brunetti P. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: First two cases. Diabetes Care 2006; 29: 137–8
- Calafiore R, Basta G, Ricordi C. Microencapsulation of pancreatic islets: Theoretical principles, technologies and practice. RG Landes, New York 1995
- Castner DG, Ratner BD. Biomaterial surface science: Foundations to frontiers. Surface Sci 2002; 500: 28–60
- Chang TM. Semipermeable microcapsules. Science 1964; 146: 524–5
- Clayton HA, London NJM, Colloby PS, Bell PRF, James RFL. The effect of capsule composition on the biocompatibility of alginate-poly-L-lysine capsules. J Microencapsul 1991; 8: 221–33
- Collier TO, Jenney CR, DeFife KM, Anderson JM. Protein adsorption on chemically modified surfaces. Biomed Sci Instrum 1997; 33: 178–83
- Collins JF, Jones MA. Connective tissue proteins of the baboon lung: Concentration, content and synthesis of collagen in the normal lung. Connect Tissue Res 1978; 5: 211–15
- de Groot M, Schuurs TA, van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res 2004; 121: 141–50
- de Vos P, Faas MM, Strand B, Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006; 32: 5603–17
- de Vos P, Straaten JF, Nieuwenhuizenn AG, Groot M, Ploeg RJ, Haan BJ, Schilfgaarde R. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?. Diabetes 1999; 48: 1381–8
- Duvivier-Kali VF, Omer A, Lopez-Avalos MD, O’Neil JJ, Weir GC. Survival of microencapsulated adult pig islets in mice in spite of an antibody response. Am J Transplant 2004; 4: 1991–2000
- Duvivier-Kali VF, Omer A, Parent RJ, O’Neil JJ, Weir GC. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 2001; 50: 1698–705
- Elliott RB, Escobar L, Tan PL, Garkavenko O, Calafiore R, Basta P, Vasconcellos AV, Emerich DF, Thanos C, Bambra C. Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant Proc 2005; 37: 3505–8
- Foster JL, Williams G, Williams LJ, Tuch BE. Differentiation of transplanted microencapsulated fetal pancreatic cells. Transplantation 2007; 83: 1440–8
- Fritschy WM, De Vos P, Groen H, Klatter FA, Pasma A, Wolters GH, Van Schilfgaarde R. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats. Transplant Int 1994; 7: 264–71
- King A, Sandler S, Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res 2001; 573: 374–83
- Ménard M, Dusseault J, Langlois G, Baille WE, Tam SK, Yahia L, Zhu XX, Hallé JP. Role of protein contaminants in the immunogenicity of alginates. J Biomed Mater Res B 2010; 93: 333–40
- Mezey E, Potter JJ, French SW, Tamura T, Halsted CH. Effect of chronic ethanol feeding on hepatic collagen in the monkey. Hepatology 1983; 3: 41–4
- Mørch YA, Donati I, Strand BL, Skjåk-Braek G. Effect of Ca2+, Ba2+, and Sr2+ on alginate microbeads. Biomacromolecules 2006; 7: 1471–80
- Omer A, Duvivier-Kali VF, Trivedi N, Wilmot K, Bonner-Weir S, Weir GC. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 2003; 52: 69–75
- Qi M, Strand BL, Mørch Y, Lacik I, Wang Y, Salehi P, Barbaro B, Gangemi A, Kuechle J, Romagnoli T, et al. Encapsulation of human islets in novel inhomogeneous alginate-Ca2+/Ba2+ microbeads: In vitro and in vivo function. Artif Cells Blood Substit Immobil 2008; 36: 403–20
- Schneider S, Feilen PJ, Brunnenmeier F, Minnemann T, Zimmermann H, Zimmermann U, Weber MM. Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent diabetic mice. Diabetes 2005; 54: 687–93
- Silva AI, de Matos AN, Brons IG, Mateus M. An overview on the development of a bio-artificial pancreas as a treatment of insulin-dependent diabetes mellitus. Med Res Rev 2006; 26: 181–222
- Skjåk-Braek G, Grasdalen H, Smidsrød O. Inhomogeneous polysaccharide ionic gels. Carbohyd Polym 1989; 10: 31–54
- Soon-Shiong P, Otterlei M, Skjåk-Broek G, Smidsrod O, Heintz R, Lanza RP, Espevik T. An immunological basis for the fibrotic reaction to implanted microcapsules. Transplant Proc 1991; 23: 758–9
- Strand BK, Ryan L, In’t Veld P, Kulseng B, Rokstad AM, Skjåk-Braek G, Espevik T. Poly-l-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant 2001; 10: 263–77
- Tang L, Eaton JW. Fibrin (ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 1993; 178: 2147–56
- Tuch BE, Keogh GW, Williams LJ, Wu W, Foster JL, Vaithilingam V, Philips R. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 2009; 32: 1887–9
- Vaithilingam V, Oberholzer J, Guillemin GJ, Tuch BE. Beneficial effects of desferrioxamine on encapsulated human islets-in vitro and in vivo study. Am J Transplant 2010; 10: 1961–9
- Vandenbossche GM, Bracke ME, Cuvelier CA, Bortier HE, Mareel MM, Remon JP. Host reaction against empty alginate – polylysine microcapsules. Influence of preparation procedure. J Pharm Pharmacol 1993a; 45: 115–20
- Vandenbossche GMR, Van Oostveld P, Demeester J, Remon JP. The molecular weight cut-off of microcapsules is determined by the reaction between alginate and polylysine. Biotechnol Bioeng 1993b; 42: 381–6
- Zhang WJ, Laue C, Hyder A, Schrezenmeir J. Purity of alginate affects the viability and fibrotic overgrowth of encapsulated porcine islet xenografts. Transplant Proc 2001; 33: 3517–19